ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,750Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 97

$1.03M Total Retail Price of All Prescriptions

Rank: 4 out of 97

666 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 666 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 666 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 22,626 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 1,049 1,022 1 3
LEVOTHYROXINE SODIUM 1,014 979 2 1
OMEPRAZOLE 950 869 3 5
PRAVASTATIN SODIUM 654 611 4 28
METOPROLOL TARTRATE 621 592 5 7
LISINOPRIL 605 550 6 4
HYDROCHLOROTHIAZIDE 590 585 7 9
WARFARIN SODIUM 581 557 8 11
LOSARTAN POTASSIUM 494 490 9 13
SIMVASTATIN 457 436 10 2
POTASSIUM CHLORIDE 429 420 11 10
AMLODIPINE BESYLATE 400 389 12 6
SERTRALINE HCL 395 385 13 16
TRAMADOL HCL 380 361 14 21
METOPROLOL SUCCINATE 362 342 15 8
ALENDRONATE SODIUM 347 345 16 19
GABAPENTIN 321 275 17 18
ALLOPURINOL 310 307 18 22
DONEPEZIL HCL 309 309 19 24
METFORMIN HCL 306 283 20 12
ATORVASTATIN CALCIUM 297 280 21 14
FENTANYL 265 250 S2 22 50
ISOSORBIDE MONONITRATE ER 258 258 23 27
PAROXETINE HCL 247 235 24 56
TAMSULOSIN HCL 242 229 25 31
CRESTOR 224 216 26 29
DIGOXIN 213 200 27 26
MIRTAZAPINE 209 209 28 35
CLOPIDOGREL 198 194 29 34
JANTOVEN 196 196 30 37
ZOLPIDEM TARTRATE 186 178 31 32
CARVEDILOL 185 170 32 25
DIOVAN 183 175 33 44
JANUVIA 179 172 34 59
ENALAPRIL MALEATE 165 156 35 47
KLOR-CON 10 164 147 36 65
PEN NEEDLE 161 155 37 57
LANTUS SOLOSTAR 157 149 38 41
NAMENDA 139 126 39 38
GLIMEPIRIDE 137 135 40 39
GLIPIZIDE 131 127 41 78
PLAVIX 131 128 41 46
ATENOLOL 129 115 43 15
RANITIDINE HCL 126 125 44 67
QUETIAPINE FUMARATE 125 125 45 82
PREDNISONE 124 110 46 23
CIPROFLOXACIN HCL 122 118 47 60
HYDROCODONE-ACETAMINOPHEN 117 116 S3 48 17
RISPERIDONE 115 115 49 70
CARBIDOPA-LEVODOPA 114 114 50 61
LANTUS 108 107 51 43
PROAIR HFA 106 105 52 76
CYMBALTA 104 93 53 80
ADVAIR DISKUS 103 101 54 40
PANTOPRAZOLE SODIUM 102 102 55 53
FLUTICASONE PROPIONATE 102 90 55 52
NOVOLOG FLEXPEN 91 83 57 74
DILTIAZEM 24HR ER 88 86 58 69
TRAZODONE HCL 88 76 58 42
DILTIAZEM 24HR CD 86 81 60 73
NEXIUM 79 79 61 66
LOSARTAN-HYDROCHLOROTHIAZIDE 78 75 62 49
KLOR-CON M20 77 77 63 92
CLONIDINE HCL 77 65 63 72
CITALOPRAM HBR 77 72 63 20
DICLOFENAC SODIUM 76 73 66 142
ZETIA 75 59 67 51
SPIRONOLACTONE 74 74 68 33
ROPINIROLE HCL 73 69 69 98
LIDODERM 72 72 70 189
TRICOR 72 65 70 125
SYNTHROID 70 70 72 108
ONGLYZA 68 68 73 155
NIFEDIPINE ER 68 68 73 118
DILTIAZEM ER 67 67 75 85
TRIAMTERENE-HCTZ 66 66 76 30
DOXAZOSIN MESYLATE 64 64 77 45
VERAPAMIL ER 63 63 78 90
HUMALOG 63 59 78 77
LEVOFLOXACIN 62 57 80 101
CELEBREX 59 59 81 95
BUSPIRONE HCL 59 59 81 107
PRAMIPEXOLE DIHYDROCHLORIDE 58 54 83 136
IRBESARTAN 58 58 83 216
CYCLOBENZAPRINE HCL 58 47 R 83 132
MISOPROSTOL 57 57 86 220
SPIRIVA 55 55 87 48
VENTOLIN HFA 54 53 88 170
BENAZEPRIL HCL 54 54 88 109
NOVOFINE AUTOCOVER 54 54 88 223
POLYETHYLENE GLYCOL 3350 53 50 91 55
MUPIROCIN 53 42 91 226
LIPITOR 52 52 93 91
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 93 148
FINASTERIDE 52 40 93 58
RENVELA 51 31 96 121
IBUPROFEN 51 51 96 126
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 44 98 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.